KALEIDO BIOSCIENCES, INC.

Analyst Reco. Kaleido Biosciences, Inc.

Equities

KLDO

US4833471000

Market Closed - OTC Markets Other stock markets 09:14:37 01/05/2024 pm IST			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	+9,900.00%

2022	Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P Global BMI Index	CI
2022	Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P TMI Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chardan Cuts Kaleido Biosciences to Neutral From Buy, PT to $1.70 From $3 After Securities Filing Discloses Strategic Review, Potential Liquidation, 'Extremely Limited' Active Development Initiatives in Pipeline	04/22/04	MT
History shows stocks can weather rate hike cycle	16/22/16	RE
Chardan Adjusts Kaleido Biosciences' Price Target to $3 from $11, Keeps Buy Rating	31/22/31	MT
Piper Sandler Adjusts Kaleido Biosciences' Price Target to $4 From $19, Reiterates Overweight Rating	31/22/31	MT
Chardan Adjusts Price Target on Kaleido Biosciences to $11 From $15 on Pipeline Assets Update, Maintains Buy Rating	12/21/12	MT
JMP Securities Adjusts Price Target on Kaleido Biosciences to $22 From $25, Maintains Market Outperform Rating	03/21/03	MT
KALEIDO BIOSCIENCES : Morgan Stanley Downgrades Kaleido Biosciences to Underweight from Equalweight, Adjusts Price Target to $3 from $12	19/21/19	MT
KALEIDO BIOSCIENCES : Chardan Adjusts Price Target on Kaleido Biosciences to $15 From $17.50, Maintains Buy Rating	04/21/04	MT
KALEIDO BIOSCIENCES : Piper Sandler Starts Kaleido Biosciences at Overweight With $19 Price Target	09/21/09	MT
KALEIDO BIOSCIENCES : Chardan Adjusts Price Target on Kaleido Biosciences to $17.50 From $10, Reiterates Buy Rating	15/21/15	MT
KALEIDO BIOSCIENCES : JMP Securities Starts Kaleido Biosciences at Market Outperform With $22 Price Target	23/20/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer